Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Prostate cancer Stories

2014-03-18 08:32:17

Experimental drug designed to fight abdominal cancers passes important test SYDNEY, March 18, 2014 /PRNewswire/ -- Novogen Limited [ASX:NRT; NASDAQ:NVGN] and its joint venture company with Yale University, CanTx Inc, today announced an important milestone with lead candidate drug, Trx-1, demonstrating a potent anti-cancer effect in mice xenografted with human ovarian cancer stem cells. http://photos.prnewswire.com/prnvar/20131220/NY36990LOGO CanTx is seeking a novel approach to...

2014-03-17 08:29:07

HOUSTON, March 17, 2014 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers. "Our collaboration with MedImmune, a leader in the field of immunotherapy, will draw on the strengths of both institutions to push ahead for more effective...

2014-03-16 23:01:40

Researchers say resveratrol slows cancer growth without the toxicity and irritation of chemotherapy. Raleigh, NC (PRWEB) March 16, 2014 A new report published on PLoS One and detailed by Cancer Monthly suggests that a natural phenol credited with giving red wine its anti-aging properties may also help fight bladder cancer. Bladder cancer accounts for about 2.6% of cancer deaths in the US and is more prevalent in diabetics than in the general public. Certain drugs, including the drug...

2014-03-14 23:21:04

Indian researchers say a simple urine test could offer a less invasive diagnostic solution for early stage bladder cancer. Raleigh, NC (PRWEB) March 14, 2014 A study published in the Asian Pacific Journal of Clinical Oncology and detailed by Cancer Monthly suggests that a compound found in urine could be used to detect early bladder cancer as well or better than current tests. Bladder cancer occurs in about 30 in 100,000 people in the US, but is slightly higher in diabetics, especially...

2014-03-14 12:28:49

WASHINGTON, March 14, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation is inviting lung cancer patients/survivors from across the nation to register for the fourth annual national LUNGevity HOPE Summit to be held on May 2- 4, 2014, at the Key Bridge Marriott in Arlington, VA. The two-day meeting, kicking off Lung Cancer Hope Month, is designed for people living with lung cancer of all ages and stages of the disease, currently in or out of treatment. LUNGevity HOPE Summits provide an...

2014-03-13 12:28:59

WASHINGTON, March 13, 2014 /PRNewswire-USNewswire/ -- In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer. In Dec. 2013, the United States...

2014-03-12 12:28:20

BETHESDA, Md., March 12, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted false statements and material distortions made by Adam Feuerstein in an article on Tuesday, March 11. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Feuerstein falsely accused NW Bio of manipulating its news by delaying announcement of the Hospital Exemption...

2014-03-11 23:22:25

UVA study’s surprising finding: Direct treatment of tumor prolongs survival. Charlottesville, VA (PRWEB) March 11, 2014 Contrary to the standard approach to treating metastatic prostate cancer, direct treatment of the primary tumor appears to prolong survival significantly, a new study suggests. The surprising findings have prompted the researchers to launch clinical trials that could upend the accepted treatment of the disease. Prostate Cancer Survival Rate Prostate cancer is the most...

2014-03-11 16:26:27

Conference call to be held on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash. and VANCOUVER, British Columbia, March 11, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and anticipated near-term milestones and announced fourth quarter and year end 2013 financial results. Clinical Developments and Anticipated Near-term Milestones -- Custirsen -- The SYNERGY Phase 3 trial is designed to...

2014-03-11 08:29:35

ROCKVILLE, Md., March 11, 2014 /PRNewswire/ -- Creatv MicroTech, Inc. collaborates with cancer researchers from a number of universities to study circulating tumor cells (CTCs) in the blood of cancer patients. When cancers become advanced, tumor cells from the primary tumor can enter the bloodstream and cause metastasis at another organ - such as liver, lung, bone, or the brain - with deadly effect. While researching the biological implications of CTC spread, Creatv's research team found a...